Brussels, 01/02/2006 (Agence Europe) - The European Commission has authorised the investment capital groups ABN Amro and L Capital 2 FCPR to take possession of Sanutri, a subsidiary of the Swiss group Novartis and which is active in the sales of diet food products (under the brand names "Gerblé", "Céréal", "Gerlinéa" and "Milical"), as the operation poses no problems in terms of competition. L Capital already controls Forté Pharma, a company which is active, mainly in France, in the...